tetano
Editor, Senior Moderator
CMAJ
. 2020 May 27;cmaj.200794.
doi: 10.1503/cmaj.200794. Online ahead of print.
Baseline Characteristics and Outcomes of Patients With COVID-19 Admitted to Intensive Care Units in Vancouver, Canada: A Case Series
Anish R Mitra[SUP] 1 [/SUP], Nicholas A Fergusson[SUP] 1 [/SUP], Elisa Lloyd-Smith[SUP] 1 [/SUP], Andrew Wormsbecker[SUP] 1 [/SUP], Denise Foster[SUP] 1 [/SUP], Andrei Karpov[SUP] 1 [/SUP], Sarah Crowe[SUP] 1 [/SUP], Greg Haljan[SUP] 1 [/SUP], Dean R Chittock[SUP] 1 [/SUP], Hussein D Kanji[SUP] 1 [/SUP], Mypinder S Sekhon[SUP] 1 [/SUP], Donald E G Griesdale[SUP] 1 [/SUP]
Affiliations
Abstract
Background: Pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with high intensive care unit (ICU) mortality. We aimed to describe the clinical characteristics and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19) in a Canadian setting.
Methods: We conducted a retrospective case series of critically ill patients with laboratory-confirmed SARS-CoV-2 infection consecutively admitted to 1 of 6 ICUs in Metro Vancouver, British Columbia, Canada, between Feb. 21 and Apr. 14, 2020. Demographic, management and outcome data were collected by review of patient charts and electronic medical records.
Results: Between Feb. 21 and Apr. 14, 2020, 117 patients were admitted to the ICU with a confirmed diagnosis of COVID-19. The median age was 69 (interquartile range [IQR] 60-75) years, and 38 (32.5%) were female. At least 1 comorbidity was present in 86 (73.5%) patients. Invasive mechanical ventilation was required in 74 (63.2%) patients. The duration of mechanical ventilation was 13.5 (IQR 8-22) days overall and 11 (IQR 6-16) days for patients successfully discharged from the ICU. Tocilizumab was administered to 4 patients and hydroxychloroquine to 1 patient. As of May 5, 2020, a total of 18 (15.4%) patients had died, 12 (10.3%) remained in the ICU, 16 (13.7%) were discharged from the ICU but remained in hospital, and 71 (60.7%) were discharged home.
Interpretation: In our setting, mortality in critically ill patients with COVID-19 admitted to the ICU was lower than in previously published studies. These data suggest that the prognosis associated with critical illness due to COVID-19 may not be as poor as previously reported.
. 2020 May 27;cmaj.200794.
doi: 10.1503/cmaj.200794. Online ahead of print.
Baseline Characteristics and Outcomes of Patients With COVID-19 Admitted to Intensive Care Units in Vancouver, Canada: A Case Series
Anish R Mitra[SUP] 1 [/SUP], Nicholas A Fergusson[SUP] 1 [/SUP], Elisa Lloyd-Smith[SUP] 1 [/SUP], Andrew Wormsbecker[SUP] 1 [/SUP], Denise Foster[SUP] 1 [/SUP], Andrei Karpov[SUP] 1 [/SUP], Sarah Crowe[SUP] 1 [/SUP], Greg Haljan[SUP] 1 [/SUP], Dean R Chittock[SUP] 1 [/SUP], Hussein D Kanji[SUP] 1 [/SUP], Mypinder S Sekhon[SUP] 1 [/SUP], Donald E G Griesdale[SUP] 1 [/SUP]
Affiliations
- PMID: 32461326
- DOI: 10.1503/cmaj.200794
Abstract
Background: Pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with high intensive care unit (ICU) mortality. We aimed to describe the clinical characteristics and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19) in a Canadian setting.
Methods: We conducted a retrospective case series of critically ill patients with laboratory-confirmed SARS-CoV-2 infection consecutively admitted to 1 of 6 ICUs in Metro Vancouver, British Columbia, Canada, between Feb. 21 and Apr. 14, 2020. Demographic, management and outcome data were collected by review of patient charts and electronic medical records.
Results: Between Feb. 21 and Apr. 14, 2020, 117 patients were admitted to the ICU with a confirmed diagnosis of COVID-19. The median age was 69 (interquartile range [IQR] 60-75) years, and 38 (32.5%) were female. At least 1 comorbidity was present in 86 (73.5%) patients. Invasive mechanical ventilation was required in 74 (63.2%) patients. The duration of mechanical ventilation was 13.5 (IQR 8-22) days overall and 11 (IQR 6-16) days for patients successfully discharged from the ICU. Tocilizumab was administered to 4 patients and hydroxychloroquine to 1 patient. As of May 5, 2020, a total of 18 (15.4%) patients had died, 12 (10.3%) remained in the ICU, 16 (13.7%) were discharged from the ICU but remained in hospital, and 71 (60.7%) were discharged home.
Interpretation: In our setting, mortality in critically ill patients with COVID-19 admitted to the ICU was lower than in previously published studies. These data suggest that the prognosis associated with critical illness due to COVID-19 may not be as poor as previously reported.